MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling

scientific article

MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1033264879
P356DOI10.1186/S40709-015-0035-2
P932PMC publication ID4619013
P698PubMed publication ID26500892
P5875ResearchGate publication ID283260574

P2093author name stringYing Fang
Yan Fu
Changyan Xu
P2860cites workPTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alphaQ24337070
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transitionQ24646324
The basics of epithelial-mesenchymal transitionQ24652992
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivoQ24657924
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNAQ24672429
Epithelial-mesenchymal plasticity in carcinoma metastasisQ26859804
MicroRNA expression profiles classify human cancersQ28032481
MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancerQ28385520
MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancerQ33590704
Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targetsQ33711948
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samplesQ33891538
MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1Q33999853
Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinomaQ34441361
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancerQ34985302
Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitroQ35010133
Clinically relevant microRNAs in ovarian cancerQ35204609
Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancerQ35919161
MicroRNA expression and function in cancerQ36637333
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transitionQ37059954
Regulation of microRNAs by epigenetics and their interplay involved in cancerQ37418150
Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experienceQ38161377
MicroRNAs as prognostic markers in ovarian cancer.Q38205688
Oncogenes associated with drug resistance in ovarian cancerQ38226577
MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell linesQ38922911
Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian CancerQ40949515
Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers.Q42255764
Ovarian cancer: a molecularly insidious diseaseQ43114620
[Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro].Q50467951
Clinical application of HE4 and CA125 in ovarian cancer type I and type II detection and differential diagnosis.Q53570674
Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan.Q53629574
Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.Q54264657
Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients.Q54623612
P921main subjectmicroRNAQ310899
ovarian carcinomaQ18556145
P304page(s)12
P577publication date2015-10-22
P1433published inJournal of biological research (Thessalonike, Greece)Q26842888
P1476titleMicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling
P478volume22

Reverse relations

cites work (P2860)
Q36070798Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma
Q91596428Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Q90451191Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p
Q48041255Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6.
Q57476011LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN
Q30244282MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications
Q49478023MicroRNA-17-5p contributes to osteoarthritis progression by binding p62/SQSTM1.
Q37298302MicroRNA-17-5p promotes gastric cancer proliferation, migration and invasion by directly targeting early growth response 2
Q51334810MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Q39382756MicroRNA-mediated drug resistance in ovarian cancer
Q39333266MicroRNAs in gynecological cancers: Small molecules with big implications
Q26773316Oncogenic MicroRNAs: Key Players in Malignant Transformation
Q47193672Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis
Q58759827Potential role of the HOXD8 transcription factor in cisplatin resistance and tumour metastasis in advanced epithelial ovarian cancer
Q92636165Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
Q42658274The Different Mechanisms of Cancer Drug Resistance: A Brief Review.
Q37626754miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer
Q92748185miRNA profile in ovarian cancer
Q92617023miRNA-17 promotes nasopharyngeal carcinoma radioresistance by targeting PTEN/AKT
Q58799032miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer

Search more.